Inhibrx Biosciences Inc (INBX)
EBITDA Growth
-22.64%
Quarterly · Period ending:
INBX EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-22.64%period ending
Latest reported-22.64%period ending
INBX Quarterly EBITDA YoY % (49.97% → -22.64%)
Year-over-year change
High-resolution chart · PNG
INBX ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -22.6439% | |
| 26.415% | |
| 38.3479% | |
| 26.9395% | |
| -101.3333% | |
| 43.1116% | |
| 46.3854% | |
| 0.5308% | |
| 4,897.8017% | |
| -71.0264% | |
| -149.9886% | |
| -45.9352% | |
| -13.3487% | |
| -43.1939% | |
| -84.3117% | |
| -60.4821% | |
| -75.777% | |
| -57.1037% | |
| -13.342% | |
| -18.9292% | |
| -15.216% | |
| -5.2234% | |
| -2.0101% | |
| 3.1921% | |
| -287.6088% | |
| -511.6008% | |
| -325.367% | |
| 32.7894% | |
| 67.4696% | |
| 49.9678% |